Clinical Trial Update: Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

View source ↗

Summary

This clinical trial entry outlines PROMISE, a study aimed at predicting progression to multiple myeloma in a high-risk screened population. It is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Multiple Myeloma | Status: RECRUITING